Thomas Krogh
Direttore operativo presso VERITAS FARMS, INC.
Posizioni attive di Thomas Krogh
Società | Posizione | Inizio | Fine |
---|---|---|---|
VERITAS FARMS, INC. | Direttore operativo | 25/08/2023 | - |
Corporate Officer/Principal | 01/01/2020 | 25/08/2023 |
Storia della carriera di Thomas Krogh
Precedenti posizioni note di Thomas Krogh
Società | Posizione | Inizio | Fine |
---|---|---|---|
CBR International Corp.
CBR International Corp. Miscellaneous Commercial ServicesCommercial Services Part of Novotech Holdings Pty Ltd., Novotech Drug Development Consulting (formerly CBR International Corp.) is a full-service product development, clinical oversight, and regulatory operations group. The company is based in Boulder, CO. CBR International was acquired by Novotech Holdings Pty Ltd. on January 09, 2023. Novotech Drug Development Consulting provides comprehensive "lab to launch" program development services and is currently assisting companies with COVID-19 development programs and FDA's Coronavirus Treatment Acceleration Program (CTAP). The company was founded in 1999 by Jeanne M. Novak, who has been the CEO since 1999. | Corporate Officer/Principal | - | - |
Formazione di Thomas Krogh
University of Denver | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Settori
Process Industries | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
VERITAS FARMS, INC. | Process Industries |
Aziende private | 1 |
---|---|
CBR International Corp.
CBR International Corp. Miscellaneous Commercial ServicesCommercial Services Part of Novotech Holdings Pty Ltd., Novotech Drug Development Consulting (formerly CBR International Corp.) is a full-service product development, clinical oversight, and regulatory operations group. The company is based in Boulder, CO. CBR International was acquired by Novotech Holdings Pty Ltd. on January 09, 2023. Novotech Drug Development Consulting provides comprehensive "lab to launch" program development services and is currently assisting companies with COVID-19 development programs and FDA's Coronavirus Treatment Acceleration Program (CTAP). The company was founded in 1999 by Jeanne M. Novak, who has been the CEO since 1999. | Commercial Services |
- Borsa valori
- Insiders
- Thomas Krogh
- Esperienza